Public Company Healthcare

Getinge

Gothenburg, Sweden

Getinge provides products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, and life science—serving healthcare providers and life science customers globally.

Focus Areas
Intensive care solutions, Cardiovascular procedures, Operating room systems
Website
getinge.com

Tracked deals

3

3 tracked deals across 2023-2024.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

3 buyout

Getinge Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for Getinge. 2 2023 1 2024

Supporting Data

Recent Transactions

  • Getinge Acquires Paragonix Technologies
    August 22, 2024
    Buyer
    Getinge
    Target
    Paragonix Technologies
    Seller
    Signet Healthcare Partners
    Industry
    Medical Devices
    Location
    Massachusetts, United States
    Type
    Buyout

    Getinge has completed the acquisition of Paragonix Technologies, a U.S. developer of organ preservation devices and transplant logistics services, for an estimated total consideration of USD 477 million (including earn-outs). The deal will make Paragonix a wholly owned subsidiary of Getinge and is intended to expand Getinge's transplant product portfolio and bring Paragonix's technologies to new global markets.

  • Getinge Acquires Healthmark Industries Co. Inc.
    October 11, 2023
    Buyer
    Getinge
    Target
    Healthmark Industries Co. Inc.
    Industry
    Medical Devices
    Location
    Michigan, United States
    Type
    Buyout

    Getinge (Gothenburg, Sweden) has acquired 100% of Healthmark Industries Co. Inc. (Fraser, Michigan, USA) for approximately USD 320 million, a deal that closed following the HSR waiting period. Healthmark, a maker of instrument-care and infection-control consumables with ~400 employees and expected FY2023 net sales of about USD 126 million, will complement Getinge’s sterile reprocessing equipment, consumables and software and accelerate Healthmark’s international expansion.

  • Getinge Acquires High Purity New England
    May 31, 2023
    Buyer
    Getinge AB
    Target
    High Purity New England, Inc.
    Seller
    Shareholders of High Purity New England (including founder/CEO Mark A. Sitcoske)
    Industry
    Biotechnology
    Location
    Rhode Island, United States
    Type
    Buyout

    Getinge AB has agreed to acquire 100% of High Purity New England (HPNE), a U.S.-based provider of custom single-use solutions for bioprocessing, for approximately SEK 1,300 million (USD 120 million) in cash plus a potential earn-out. The acquisition strengthens Getinge Life Science’s biopharma capabilities and expands its single-use product offering; HPNE is headquartered in Smithfield, Rhode Island and has roughly 150 employees.

Related Acquisition Pages

Medical Devices Buyers & Acquisitions 2 tracked deals by Getinge. Biotechnology Buyers & Acquisitions 1 tracked deal by Getinge. Acquisitions in Massachusetts 1 tracked deal by Getinge. Acquisitions in Michigan 1 tracked deal by Getinge. Acquisitions in Rhode Island 1 tracked deal by Getinge.

Related articles

Selling a company? Get in front of buyers like Getinge

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →